Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young men.
- DOI
- 10.1111/bcp.16091
- Published
- 2024 Aug
- Container
- British journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bcp.16091,
title = {Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young men.},
author = {Friedrich C and Singh D and Francke K and Klein S and Hetzel T and Zolk O and Gashaw I and Scheerans C and Morice A},
year = {2024},
journal = {British journal of clinical pharmacology},
doi = {10.1111/bcp.16091},
url = {https://doi.org/10.1111/bcp.16091}
}RIS
TY - JOUR TI - Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young men. AU - Friedrich C AU - Singh D AU - Francke K AU - Klein S AU - Hetzel T AU - Zolk O AU - Gashaw I AU - Scheerans C AU - Morice A PY - 2024 JO - British journal of clinical pharmacology DO - 10.1111/bcp.16091 UR - https://doi.org/10.1111/bcp.16091 ER -
APA
C, F., D, S., K, F., S, K., T, H., O, Z., I, G., C, S., & A, M. (2024). Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young men.. British journal of clinical pharmacology. https://doi.org/10.1111/bcp.16091
Source records
- pubmed · retrieved 2026-09-25T10:23:20.988Z
- europe-pmc · retrieved 2026-09-25T10:23:21.009Z